BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 16911137)

  • 1. Decision aids for familial breast cancer: exploring women's views using focus groups.
    Rapport F; Iredale R; Jones W; Sivell S; Edwards A; Gray J; Elwyn G
    Health Expect; 2006 Sep; 9(3):232-44. PubMed ID: 16911137
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exploring the requirements for a decision aid on familial breast cancer in the UK context: a qualitative study with patients referred to a cancer genetics service.
    Iredale R; Rapport F; Sivell S; Jones W; Edwards A; Gray J; Elwyn G
    J Eval Clin Pract; 2008 Feb; 14(1):110-5. PubMed ID: 18211652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interactive patient decision aids for women facing genetic testing for familial breast cancer: a systematic web and literature review.
    Williams L; Jones W; Elwyn G; Edwards A
    J Eval Clin Pract; 2008 Feb; 14(1):70-4. PubMed ID: 18211647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exploring the black box of a decision aid: what information do patients select from an interactive Cd-Rom on treatment options in breast cancer?
    Molenaar S; Sprangers M; Oort F; Rutgers E; Luiten E; Mulder J; van Meeteren M; de Haes H
    Patient Educ Couns; 2007 Jan; 65(1):122-30. PubMed ID: 16945498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overdetection in breast cancer screening: development and preliminary evaluation of a decision aid.
    Hersch J; Jansen J; Barratt A; Irwig L; Houssami N; Jacklyn G; Thornton H; Dhillon H; McCaffery K
    BMJ Open; 2014 Sep; 4(9):e006016. PubMed ID: 25256188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Why Breast Cancer Risk by the Numbers Is Not Enough: Evaluation of a Decision Aid in Multi-Ethnic, Low-Numerate Women.
    Kukafka R; Yi H; Xiao T; Thomas P; Aguirre A; Smalletz C; David R; Crew K
    J Med Internet Res; 2015 Jul; 17(7):e165. PubMed ID: 26175193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic testing for susceptibility to breast cancer: findings from women's focus groups.
    Tessaro I; Borstelmann N; Regan K; Rimer BK; Winer E
    J Womens Health; 1997 Jun; 6(3):317-27. PubMed ID: 9201666
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and pilot testing of two decision aids for individuals considering genetic testing for cancer risk.
    Wakefield CE; Meiser B; Homewood J; Peate M; Kirk J; Warner B; Lobb E; Gaff C; Tucker K
    J Genet Couns; 2007 Jun; 16(3):325-39. PubMed ID: 17318456
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A qualitative study on Singaporean women's views towards breast cancer screening and Single Nucleotide Polymorphisms (SNPs) gene testing to guide personalised screening strategies.
    Wong XY; Chong KJ; van Til JA; Wee HL
    BMC Cancer; 2017 Nov; 17(1):776. PubMed ID: 29162038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Black and Minority Ethnic women's decision-making for risk reduction strategies after BRCA testing: Use of context and knowledge.
    Machirori M; Patch C; Metcalfe A
    Eur J Med Genet; 2019 May; 62(5):376-384. PubMed ID: 30550831
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of a computer-based decision aid on knowledge, perceptions, and intentions about genetic testing for breast cancer susceptibility: a randomized controlled trial.
    Green MJ; Peterson SK; Baker MW; Harper GR; Friedman LC; Rubinstein WS; Mauger DT
    JAMA; 2004 Jul; 292(4):442-52. PubMed ID: 15280342
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improving the referral process for familial breast cancer genetic counselling: findings of three randomised controlled trials of two interventions.
    Wilson BJ; Torrance N; Mollison J; Wordsworth S; Gray JR; Haites NE; Grant A; Campbell MK; Miedyzbrodzka Z; Clarke A; Watson MS; Douglas A
    Health Technol Assess; 2005 Feb; 9(3):iii-iv, 1-126. PubMed ID: 15694064
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decision aids for people facing health treatment or screening decisions.
    Stacey D; Légaré F; Col NF; Bennett CL; Barry MJ; Eden KB; Holmes-Rovner M; Llewellyn-Thomas H; Lyddiatt A; Thomson R; Trevena L; Wu JH
    Cochrane Database Syst Rev; 2014 Jan; (1):CD001431. PubMed ID: 24470076
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quality of decision aids developed for women at average risk of breast cancer eligible for mammographic screening: Systematic review and assessment according to the International Patient Decision Aid Standards instrument.
    Hild S; Johanet M; Valenza A; Thabaud M; Laforest F; Ferrat E; Rat C;
    Cancer; 2020 Jun; 126(12):2765-2774. PubMed ID: 32267546
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A qualitative study on a decision aid for breast cancer screening: Views from women and health professionals.
    Toledo-Chávarri A; Rué M; Codern-Bové N; Carles-Lavila M; Perestelo-Pérez L; Pérez-Lacasta MJ; Feijoo-Cid M;
    Eur J Cancer Care (Engl); 2017 May; 26(3):. PubMed ID: 28145105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Women's perceptions of personalized risk-based breast cancer screening and prevention: An international focus group study.
    Rainey L; Jervaeus A; Donnelly LS; Evans DG; Hammarström M; Hall P; Wengström Y; Broeders MJM; van der Waal D
    Psychooncology; 2019 May; 28(5):1056-1062. PubMed ID: 30848018
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of two evidence-based decision aids for female BRCA1/2 mutation carriers in Germany: study protocol for a randomised controlled parallel-group trial.
    Kautz-Freimuth S; Redaèlli M; Isselhard A; Shukri A; Vodermaier A; Rhiem K; Schmutzler R; Stock S
    Trials; 2022 Feb; 23(1):157. PubMed ID: 35172875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of decision aids for female BRCA1 and BRCA2 mutation carriers in Germany to support preference-sensitive decision-making.
    Kautz-Freimuth S; Redaèlli M; Rhiem K; Vodermaier A; Krassuski L; Nicolai K; Schnepper M; Kuboth V; Dick J; Vennedey V; Wiedemann R; Schmutzler R; Stock S
    BMC Med Inform Decis Mak; 2021 Jun; 21(1):180. PubMed ID: 34090422
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and pilot testing of a decision aid for men considering genetic testing for breast and/or ovarian cancer-related mutations (BRCA1/2).
    Juan AS; Wakefield CE; Kasparian NA; Kirk J; Tyler J; Tucker K
    Genet Test; 2008 Dec; 12(4):523-32. PubMed ID: 19072564
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Getting to the point: what women newly diagnosed with breast cancer want to know about treatment-focused genetic testing.
    Meiser B; Gleeson M; Watts K; Peate M; Zilliacus E; Barlow-Stewart K; Saunders C; Mitchell G; Kirk J
    Oncol Nurs Forum; 2012 Mar; 39(2):E101-11. PubMed ID: 22374498
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.